Free Trial

iBio (IBIO) Stock Price, News & Analysis

iBio logo
$0.82 -0.01 (-0.90%)
Closing price 08/29/2025 04:00 PM Eastern
Extended Trading
$0.80 -0.02 (-2.65%)
As of 08/29/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About iBio Stock (NYSE:IBIO)

Key Stats

Today's Range
$0.78
$0.82
50-Day Range
$0.57
$0.85
52-Week Range
$0.56
$6.89
Volume
563,945 shs
Average Volume
1.54 million shs
Market Capitalization
$16.07 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$5.00
Consensus Rating
Buy

Company Overview

iBio Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
38th Percentile Overall Score

IBIO MarketRank™: 

iBio scored higher than 38% of companies evaluated by MarketBeat, and ranked 740th out of 950 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    iBio has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    iBio has only been the subject of 1 research reports in the past 90 days.

  • Read more about iBio's stock forecast and price target.
  • Earnings Growth

    Earnings for iBio are expected to decrease in the coming year, from ($1.74) to ($2.05) per share.

  • Price to Book Value per Share Ratio

    iBio has a P/B Ratio of 0.58. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Short Interest

    There is no current short interest data available for IBIO.
  • Dividend Yield

    iBio does not currently pay a dividend.

  • Dividend Growth

    iBio does not have a long track record of dividend growth.

  • Short Interest

    There is no current short interest data available for IBIO.
  • News Sentiment

    iBio has a news sentiment score of 1.11. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 14 news articles for iBio this week, compared to 1 article on an average week.
  • Search Interest

    3 people have searched for IBIO on MarketBeat in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, iBio insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 0.58% of the stock of iBio is held by insiders.

  • Percentage Held by Institutions

    Only 7.90% of the stock of iBio is held by institutions.

  • Read more about iBio's insider trading history.
Receive IBIO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for iBio and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

IBIO Stock News Headlines

Analysts Offer Predictions for iBio Q1 Earnings
iBio Announces Closing of $50 Million Public Offering
This is my Christian duty
“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 trillion vault of untapped American wealth. Former CIA advisor Jim Rickards calls it the “Old Testament Wealth Code” — and says it could transform your financial future. He’s revealing everything in a new presentation.tc pixel
iBio Announces Pricing of $50 Million Public Offering
iBio Announces Proposed Public Offering
See More Headlines

IBIO Stock Analysis - Frequently Asked Questions

iBio's stock was trading at $2.45 on January 1st, 2025. Since then, IBIO shares have decreased by 66.6% and is now trading at $0.8177.

iBio, Inc. (NYSE:IBIO) issued its quarterly earnings data on Tuesday, November, 12th. The company reported ($0.46) earnings per share (EPS) for the quarter, hitting the consensus estimate of ($0.46).

Shares of IBIO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that iBio investors own include Fastly (FSLY), Fortinet (FTNT), Snowflake (SNOW), Tesla (TSLA), Arbor Realty Trust (ABR) and Accenture (ACN).

Company Calendar

Last Earnings
11/12/2024
Today
8/30/2025
Fiscal Year End
6/30/2026

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NYSE:IBIO
Previous Symbol
NYSE:IBIO
CIK
1420720
Employees
100
Year Founded
N/A

Price Target and Rating

High Price Target
$5.00
Low Price Target
$5.00
Potential Upside/Downside
+511.5%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$24.91 million
Net Margins
N/A
Pretax Margin
-3,795.73%
Return on Equity
-73.15%
Return on Assets
-45.51%

Debt

Debt-to-Equity Ratio
0.05
Current Ratio
1.76
Quick Ratio
1.76

Sales & Book Value

Annual Sales
$375 thousand
Price / Sales
42.86
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.41 per share
Price / Book
0.58

Miscellaneous

Outstanding Shares
19,655,000
Free Float
9,818,000
Market Cap
$16.07 million
Optionable
N/A
Beta
0.60

Social Links

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

This page (NYSE:IBIO) was last updated on 8/30/2025 by MarketBeat.com Staff
From Our Partners